seasonal influenza vaccine (live attenuated) (Protheon/Biotrion)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nameseasonal influenza vaccine (live attenuated) (Protheon/Biotrion)
Drug Alias NameMistVaxBT-V002
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Live attenuated vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesProtheon Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesProtheon Inc
Active IndicationsN/A
Inactive IndicationsInfluenza, Human

Other Information

ATC CodeN/A
Related LinksN/A